Angiotensin-converting enzyme (ACE) inhibitor prescription...

Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers

Medjebar, Soleine, Truntzer, Caroline, Perrichet, Anaïs, Limagne, Emeric, Fumet, Jean-David, Richard, Corentin, Elkrief, Arielle, Routy, Bertrand, Rébé, Cédric, Ghiringhelli, François
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2020.1836766
Date:
January, 2020
File:
PDF, 3.12 MB
2020
Conversion to is in progress
Conversion to is failed